World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2457)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

137

WORD

HTML

1629

Figures (1-1)

257

Sum=2059

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

113

Download

191

Sum=304

Apr 27, 2023 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Gao YX, Ning QQ, Yang PX, Guan YY, Liu PX, Liu ML, Qiao LX, Guo XH, Yang TW, Chen DX. Recent advances in recurrent hepatocellular carcinoma therapy. World J Hepatol 2023; 15(4): 460-476 [PMID: 37206651 DOI: 10.4254/wjh.v15.i4.460]
URL:	https://www.wjgnet.com/1007-9327/full/v15/i4/460.htm

Number	Citing Articles
1	Mohamed Wishahi. Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept. World Journal of Hepatology 2024; 16(4): 490-493 doi: 10.4254/wjh.v16.i4.490 Abstract(17) \| Core Tip(14) \| Full Article(HTML)(120) \| Full Article with Cover (PDF)-872K(4) \| Audio-323K(0) \| Peer-Review Report-143K(3) \| Answering Reviewers-166K(4) \| Full Article (PDF)-341K(7) \| Full Article (XML)-36K(4) \| Times Cited (0) \| Total Visits (224) \| Open
2	Albert Qin, Chang-Ru Wu, Ming-Chih Ho, Chan-Yen Tsai, Pei-Jer Chen. Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. International Journal of Molecular Sciences 2023; 25(1): 433 doi: 10.3390/ijms25010433
3	Shiheng Wu, Xinxing Zhang, Jin Bao, Naiying Sun, Wenjun Guo, Baogui Wang, Xingjie Yang. Hepatocellular carcinoma‑cavernous hemangioma collision tumor: A case report. Oncology Letters 2023; 27(2) doi: 10.3892/ol.2023.14207
4	Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine. World Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424 Abstract(133) \| Core Tip(119) \| Full Article(HTML)(945) \| Full Article with Cover (PDF)-3548K(87) \| Full Article (Word)-242K(19) \| Audio-234K(2) \| Peer-Review Report-224K(34) \| Answering Reviewers-264K(21) \| Full Article (PDF)-550K(67) \| Full Article (XML)-38K(16) \| Times Cited (0) \| Total Visits (2067) \| Open
5	Zijie Wu, Zehua Dong, Jiangti Luo, Weiwei Hu, Yue Tong, Xiangdong Gao, Wenbing Yao, Hong Tian, Xiaosheng Wang. A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis. Genomics 2024; 116(3): 110831 doi: 10.1016/j.ygeno.2024.110831